1 study found for:    AMG-145 20110118
Show Display Options
Rank Status Study
1 Recruiting Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Condition: Dyslipidemia
Interventions: Device: Evolocumab (AMG 145);   Device: Placebo;   Drug: Effective statin therapy

Indicates status has not been verified in more than two years